AU2001267690A1 - Use of indole-3-acetic acid derivatives in medicine - Google Patents

Use of indole-3-acetic acid derivatives in medicine

Info

Publication number
AU2001267690A1
AU2001267690A1 AU2001267690A AU6769001A AU2001267690A1 AU 2001267690 A1 AU2001267690 A1 AU 2001267690A1 AU 2001267690 A AU2001267690 A AU 2001267690A AU 6769001 A AU6769001 A AU 6769001A AU 2001267690 A1 AU2001267690 A1 AU 2001267690A1
Authority
AU
Australia
Prior art keywords
sub
groups
indole
medicine
acetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267690A
Other languages
English (en)
Inventor
Gabriele U. Dachs
Lisa K. Folkes
Olga Greco
Sharon Rossiter
Peter Wardman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Ventures Ltd
Original Assignee
Cancer Research Ventures Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Ventures Ltd filed Critical Cancer Research Ventures Ltd
Publication of AU2001267690A1 publication Critical patent/AU2001267690A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6899—Antibody-Directed Enzyme Prodrug Therapy [ADEPT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01007—Peroxidase (1.11.1.7), i.e. horseradish-peroxidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2001267690A 2000-06-30 2001-06-28 Use of indole-3-acetic acid derivatives in medicine Abandoned AU2001267690A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0016162 2000-06-30
GBGB0016162.0A GB0016162D0 (en) 2000-06-30 2000-06-30 Indole-3-acetic acid derivatives
PCT/GB2001/002872 WO2002002110A1 (en) 2000-06-30 2001-06-28 Use of indole-3-acetic acid derivatives in medicine

Publications (1)

Publication Number Publication Date
AU2001267690A1 true AU2001267690A1 (en) 2002-01-14

Family

ID=9894821

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267690A Abandoned AU2001267690A1 (en) 2000-06-30 2001-06-28 Use of indole-3-acetic acid derivatives in medicine

Country Status (8)

Country Link
US (1) US6890948B1 (de)
EP (1) EP1296676B1 (de)
AT (1) ATE258436T1 (de)
AU (1) AU2001267690A1 (de)
DE (1) DE60101914T2 (de)
ES (1) ES2215138T3 (de)
GB (1) GB0016162D0 (de)
WO (1) WO2002002110A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004218412A1 (en) 2003-02-28 2004-09-16 Oxigene, Inc. Compositions and methods with enhanced therapeutic activity
AU2007203861B2 (en) 2006-01-05 2009-11-26 Interdigital Patent Holdings, Inc. Transmitting information in mobile communications system
KR100773475B1 (ko) * 2006-07-07 2007-11-05 주식회사 웰스킨 인돌-3-아세트산을 포함하는 광감작제, 및 이를 포함하는광역학적 치료용 키트
US8580192B2 (en) * 2006-10-31 2013-11-12 Ethicon, Inc. Sterilization of polymeric materials
KR20090001013A (ko) * 2007-06-29 2009-01-08 주식회사 웰스킨 인돌-3-알킬카복실산을 함유하는 여드름 치료제 및 피지분비 억제제, 및 이를 포함하는 광역학적 치료용 키트
KR101089750B1 (ko) 2009-11-25 2011-12-07 중앙대학교 산학협력단 5―히드록시인돌초산을 포함하는 광감작용 조성물 및 이를 포함하는 암의 광역학 치료용 조성물
US8748446B2 (en) 2012-03-03 2014-06-10 Nanoquantum Sciences, Inc. Halogenated compounds for photodynamic therapy
CN105037239B (zh) * 2015-07-21 2018-04-06 苏州卡耐博生物技术有限公司 一种4‑氯吲哚‑3‑乙酸的制备方法
EP3710481A4 (de) * 2017-11-16 2021-08-18 Antigenesis LLC Systeme und verfahren für lysosominduzierten tod immunogener zellen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA957281A (en) * 1970-02-03 1974-11-05 Nathan N. Share Pharmaceutical compositions containing indole-3-acetic acid derivatives as a skeletal muscle stimulant
US3901914A (en) * 1973-11-01 1975-08-26 Merck & Co Inc 1-(substituted phosphinothioyl, phosphinyl or phosphino)-substituted indole-3-acetic acids
GB8705477D0 (en) 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
ZA939516B (en) * 1992-12-22 1994-06-06 Smithkline Beecham Corp Endothelin receptor antagonists
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
GB9609641D0 (en) * 1996-05-09 1996-07-10 Pfizer Ltd Compounds useful in therapy

Also Published As

Publication number Publication date
ATE258436T1 (de) 2004-02-15
DE60101914D1 (de) 2004-03-04
ES2215138T3 (es) 2004-10-01
EP1296676B1 (de) 2004-01-28
GB0016162D0 (en) 2000-08-23
EP1296676A1 (de) 2003-04-02
DE60101914T2 (de) 2004-10-28
WO2002002110A1 (en) 2002-01-10
US6890948B1 (en) 2005-05-10

Similar Documents

Publication Publication Date Title
AP1666A (en) Quinolinone derivatives as tyrosine kinase inhibitors.
ATE283271T1 (de) Porphyrin derivate, ihre verwendung in der photodynamischen therapie und diese enthaltende medizinische geräte
DK0524781T3 (da) Terapeutiske amider
RS99203A (en) Pyrrolopyrimidines as protein kinase inhibitors
LU91076I9 (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
MXPA03011998A (es) Pirrolopirimidinas como inhibidores de protein cinasa.
DE60003021D1 (de) Benzoesäureesterderivate, diese enthaltende zusammenstellungen und deren anwendung
AU6369900A (en) Aromatic esters of camptothecins and methods to treat cancers
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
AU2001267690A1 (en) Use of indole-3-acetic acid derivatives in medicine
FI951858A (fi) Kinoloni- ja akridonijohdannaisia virtsanpidätyskyvyttömyyden hoidossa
DE69907419D1 (en) Antitumorwirkstoffe
DE69413118T2 (de) Benzolsulfonamid-Derivate zur Behandlung der Blaseninstabilität
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
MX9708735A (es) Benzotiazoles y benzoxazoles, composiciones farmaceuticas que contienen estos compuestos y su uso y proceso para prepararlos.
SG82540A1 (en) N-substituted azabicyclo [3.2.0] heptane derivatives as neuroleptics, the preparation and use thereof
CA2374902A1 (en) Aminoalkyl substituted benzopyran derivatives for treating impaired fundic relaxation
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
EP1120415A4 (de) Substituierte isoxazolylthiophenverbindungen
EP2266566A3 (de) Nicotinamid Derivate und ihrer Verwendung als Therapeutika